Videos

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the elements of an effective interdisciplinary collaborative patient management program.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Grant E. Knowles, vice president of business development at Ardon Health, discusses how biosimilars may impact the high cost of specialty drugs.

Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.

Gregory R. Morris, chief commercial officer at VirMedica, discusses how eAccess can benefit patients and providers.

Deborah Michaelson, MS, RPh, discusses the elements of an ideal specialty pharmacy therapy management program.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

This weekly video program highlights the latest in pharmacy news, product news, and more.

This weekly video program highlights the latest in pharmacy news, product news, and more.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Marc O'Connor, chief operating officer of Curant Health, discusses efficiency in specialty pharmacy relationships.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, provides some key takeaways for pharmacists on atrial fibrillation management.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient's renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses how to improve adherence.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses why it is important that patients know which medication they should use in a particular situation.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses some ways pharmacists can improve patient adherence to novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses counseling points for both anticoagulant classes.

Dennis Williams, PharmD, FAPhA, discusses the steps pharmacists should take when a patient does not see relief from first-line therapies.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses counseling points pharmacists should make when demonstrating proper inhaler use.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what patients should consider food-wise when taking vitamin K antagonists or novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses how new technology is changing the inhaler manufacturing industry.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.

Dennis Williams, PharmD, FAPhA, discusses why it's so important to use proper technique for intranasal steroids.

Dennis Williams, PharmD, FAPhA, discusses which clinical situations can be managed by nonpharmacological treatments.